Logo image of NG

NOVAGOLD RESOURCES INC (NG) Stock Fundamental Analysis

NYSEARCA:NG - NYSE Arca - CA66987E2069 - Common Stock - Currency: USD

3.75  +0.17 (+4.75%)

After market: 3.85 +0.1 (+2.67%)

Fundamental Rating

1

Taking everything into account, NG scores 1 out of 10 in our fundamental rating. NG was compared to 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of NG have multiple concerns. NG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NG has reported negative net income.
NG had a negative operating cash flow in the past year.
In the past 5 years NG always reported negative net income.
In the past 5 years NG always reported negative operating cash flow.
NG Yearly Net Income VS EBIT VS OCF VS FCFNG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

NG has a Return On Assets of -43.54%. This is amonst the worse of the industry: NG underperforms 87.66% of its industry peers.
Industry RankSector Rank
ROA -43.54%
ROE N/A
ROIC N/A
ROA(3y)-36.73%
ROA(5y)-29.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NG Yearly ROA, ROE, ROICNG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

NG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NG Yearly Profit, Operating, Gross MarginsNG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NG remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NG has more shares outstanding
Compared to 1 year ago, NG has a worse debt to assets ratio.
NG Yearly Shares OutstandingNG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NG Yearly Total Debt VS Total AssetsNG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NG has an Altman-Z score of -23.25. This is a bad value and indicates that NG is not financially healthy and even has some risk of bankruptcy.
NG has a Altman-Z score of -23.25. This is amonst the worse of the industry: NG underperforms 94.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.25
ROIC/WACCN/A
WACCN/A
NG Yearly LT Debt VS Equity VS FCFNG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 47.82 indicates that NG has no problem at all paying its short term obligations.
The Current ratio of NG (47.82) is better than 100.00% of its industry peers.
A Quick Ratio of 47.82 indicates that NG has no problem at all paying its short term obligations.
NG has a Quick ratio of 47.82. This is amongst the best in the industry. NG outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 47.82
Quick Ratio 47.82
NG Yearly Current Assets VS Current LiabilitesNG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for NG have decreased by 0.00% in the last year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -14.61% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.77%
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NG Yearly EPS VS EstimatesNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NG. In the last year negative earnings were reported.
Also next year NG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NG Price Earnings VS Forward Price EarningsNG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NG Per share dataNG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

NG's earnings are expected to decrease with -14.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%

More info and screens

0

5. Dividend

5.1 Amount

NG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVAGOLD RESOURCES INC

NYSEARCA:NG (6/2/2025, 8:25:20 PM)

After market: 3.85 +0.1 (+2.67%)

3.75

+0.17 (+4.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-01 2025-04-01/bmo
Earnings (Next)06-24 2025-06-24/amc
Inst Owners52.09%
Inst Owner Change-3.02%
Ins Owners1.1%
Ins Owner Change397.01%
Market Cap1.50B
Analysts82
Price Target10.2 (172%)
Short Float %3.91%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.22%
Min EPS beat(2)-45.63%
Max EPS beat(2)27.18%
EPS beat(4)1
Avg EPS beat(4)-39.56%
Min EPS beat(4)-94.17%
Max EPS beat(4)27.18%
EPS beat(8)1
Avg EPS beat(8)-48.66%
EPS beat(12)1
Avg EPS beat(12)-46.31%
EPS beat(16)4
Avg EPS beat(16)-34%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.73%
ROA(5y)-29.11%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 47.82
Quick Ratio 47.82
Altman-Z -23.25
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-26.77%
EPS Next 2Y-16.06%
EPS Next 3Y-14.61%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-45.68%
EBIT Next 3Y-4.97%
EBIT Next 5YN/A
FCF growth 1Y-17.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.19%
OCF growth 3YN/A
OCF growth 5YN/A